Discover the newest research about AI innovations in π Oncology.
Revolutionizing oncology data retrieval: 9% NDCG improvement using LLMs and fine-tuned embeddings! ππ‘
AI technology can detect early prostate cancer missed by pathologists, identifying subtle tissue changes in biopsies. π§¬π
Global AI Clinical Trials: 596 studies, 62 countries, 35.6% in China. Urgent need for equitable collaboration! ππ€π
Exploring biomarkers in high-risk prostate cancer: 50-75% relapse rate post-treatment. Genomic profiling enhances precision oncology. ππ¬
New AI tool ShortStop aids in discovering microproteins in the human genome, potentially impacting health and disease research. π§¬π
AI enhances Optical Coherence Tomography (OCT) for disease detection, improving diagnostic accuracy and patient outcomes. ππ©Ί
AI in Colorectal Cancer: VGG16 Model Achieves 78.44% Accuracy for 5-Year Survival Prediction ππ€
AI models excel in interpreting mammograms, enhancing breast cancer detection rates while maintaining low recall rates. ππ©Ί
π Retinoblastoma biomarkers research shows steady growth, with China leading publications. Key hotspots include liquid biopsy and AI integration. π¬
AI enhances oncology from risk assessment to treatment, improving accuracy and personalization. Key challenges include validation and data security. π€ποΈ
